Dolca Thomas
2021 - Equillium
In 2021, Dolca Thomas earned a total compensation of $2.3M as Former Executive Vice President, Research and Development and Chief Medical Officer at Equillium.
Compensation breakdown
| Non-Equity Incentive Plan | $146,251 |
|---|---|
| Option Awards | $1,719,720 |
| Salary | $470,433 |
| Total | $2,336,404 |
Thomas received $1.7M in option awards, accounting for 74% of the total pay in 2021.
Thomas also received $146.3K in non-equity incentive plan and $470.4K in salary.
Rankings
In 2021, Dolca Thomas' compensation ranked 5,428th out of 12,415 executives tracked by ExecPay. In other words, Thomas earned more than 56.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,428 out of 12,415 | 56th |
Division Manufacturing | 2,287 out of 5,508 | 59th |
Major group Chemicals And Allied Products | 995 out of 2,378 | 58th |
Industry group Drugs | 886 out of 2,099 | 58th |
Industry Pharmaceutical Preparations | 635 out of 1,549 | 59th |
Source: SEC filing on April 13, 2022.
Thomas' colleagues
We found two more compensation records of executives who worked with Dolca Thomas at Equillium in 2021.